ELV Elevance Health

company

SEC Filings & Insider Trading Activity 2026

Business Overview

• • Core business model: Health benefits and insurance services built significantly through mergers, acquisitions, joint ventures, and strategic alliances
• • Emphasis on risks related to integration and liabilities from recent and future business combinations impacting financials and operations
• • Strategic risk focus on dependency on dividends from regulated subsidiaries constrained by state insurance laws and minimum capital requirements
• • Intangible assets $39.5B representing 32.5% of total assets, with potential impairment risk tied to business combination performance and market changes
• • Highlighted concern over maintaining credit ratings which are critical for competitive position and funding flexibility

Risk Factors

• • Risk adjustment audits by CMS and HHS OIG awaiting finalization, with potential retroactive payment adjustments impacting financial results
• • Concentration in states like California, NY, Texas, exposed to regional economic downturns affecting enrollment and revenues
• • Heavy dependence on third-party pharmacy services via CVS Agreement; failure by CVS to deliver could disrupt pharmacy operations
• • Competition and provider consolidation risks with provider groups potentially owned by competitors affecting contracting and pricing
• • Cybersecurity risks heightened by remote workforce and evolving regulations (e.g., HIPAA, CCPA, GDPR); breaches could cause fines and reputational damage

Management Discussion & Analysis

• • Revenue details and YoY change not disclosed in provided text
• • Operating gain and margin defined but no actual % figures or changes provided
• • Reportable segments: Health Benefits, CarelonRx, Carelon Services, Corporate & Other; no segment financial performance disclosed
• • No cash flow, buyback, dividend, or capex information given
• • No forward-looking management outlook, guidance, or key risks mentioned in excerpt

What are the latest ELV SEC filings in 2026?

Elevance Health (ELV) has filed a 10-K annual report on February 6, 2026, a 10-Q quarterly report on April 22, 2026, an 8-K current report on July 15, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.

When did ELV file its most recent 10-K annual report?

Elevance Health (ELV) filed its most recent 10-K annual report on February 6, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.

How do I view ELV 10-Q quarterly reports?

Elevance Health (ELV)'s most recent 10-Q quarterly report was filed on April 22, 2026. SignalX displays every ELV 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.

What 8-K current reports has ELV filed recently?

Elevance Health (ELV)'s most recent 8-K was filed on July 15, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.

Where can I find ELV insider trading activity (Form 4)?

SignalX aggregates every ELV Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.

How often does ELV file with the SEC?

Elevance Health (ELV) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new ELV filing with AI-powered analysis.

What is the difference between 10-K, 10-Q, and 8-K SEC filings?

A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Elevance Health (ELV).

What is ELV's SEC CIK number?

Elevance Health (ELV)'s SEC CIK (Central Index Key) number is 1156039. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1156039 to look up all ELV filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.

Where can I find ELV return on equity (ROE) and financial data?

SignalX extracts XBRL financial data from Elevance Health (ELV) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.